SCHEMBL8645259

SCHEMBL8645259

O=[C]CNS(=O)(=O)c1cccc2ccccc12

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN1A P35498 2/20 0.56
SCN2A Q99250 2/20 0.56
SCN3A Q9NY46 2/20 0.56
KDM4E B2RXH2 1/20 0.56
ALDH1A1 P00352 1/20 0.56
CYP1A2 P05177 1/20 0.56
CYP3A4 P08684 1/20 0.56
CYP2C9 P11712 1/20 0.56
CYP2C19 P33261 1/20 0.56
HSD17B10 Q99714 1/20 0.56
HCRTR1 O43613 1/20 0.51
SLC6A9 P48067 9/20 0.51
GBA1 P04062 1/20 0.49
F2 P00734 1/20 0.49
PRSS1 P07477 1/20 0.49
PRSS2 P07478 1/20 0.49
PRSS3 P35030 1/20 0.49
CA1 P00915 1/20 0.49
CA2 P00918 1/20 0.49
CA9 Q16790 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5012475 0.85 SCN1A (0.55) SCN1ASCN2ASCN3AKDM4EALDH1A1
SCHEMBL2878189 0.83 SCN1A (0.59) SCN1ASCN2ASCN3AKDM4EALDH1A1
SCHEMBL6006634 0.81 CYP3A4 (0.69) SCN1ASCN2ASCN3AKDM4EALDH1A1
SCHEMBL6006442 0.81 SCN1A (0.54) SCN1ASCN2ASCN3AKDM4EALDH1A1
SCHEMBL3680789 0.80 CYP3A4 (0.64) SCN1ASCN2ASCN3AKDM4EALDH1A1
SCHEMBL6006455 0.80 SCN1A (0.52) SCN1ASCN2ASCN3AKDM4EALDH1A1
SCHEMBL6006452 0.80 CYP3A4 (0.59) SCN1ASCN2ASCN3AKDM4EALDH1A1
SCHEMBL6006630 0.79 SCN1A (0.59) SCN1ASCN2ASCN3AKDM4EALDH1A1
SCHEMBL207375 0.79 SCN1A (0.59) SCN1ASCN2ASCN3AKDM4EALDH1A1
SCHEMBL13684206 0.79 SLC6A9 (0.57) SCN1ASCN2ASCN3AKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0442843-B1 Inhibitors for the anticoagulant pretreatment of blood samples PENTAPHARM AG (CH) 1998-09-09 EP claimed
US-5187102-A Treating blood sample with thrombin inhibitor which does not bind bivalent cations PENTAPHARM AG (CH) 1993-02-16 US claimed
EP-0442843-A1 Inhibitors for the anticoagulant pretreatment of blood samples Pentapharm A.G. (CH) 1991-08-21 EP claimed
EP-0442843-B1 Inhibitors for the anticoagulant pretreatment of blood samples PENTAPHARM AG (CH) 1998-09-09 EP disclosed
US-5187102-A Treating blood sample with thrombin inhibitor which does not bind bivalent cations PENTAPHARM AG (CH) 1993-02-16 US disclosed
EP-0442843-A1 Inhibitors for the anticoagulant pretreatment of blood samples Pentapharm A.G. (CH) 1991-08-21 EP disclosed